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Introduction
Juvenile idiopathic arthritis (JIA) refers to chronic child-
hood arthritides of unknown aetiology with onset before
the age of 16 and persisting for more than 6 weeks.
According to ILAR criteria patients are divided into 7
categories of which oligoarthritis is the most common one
in western countries. It is further distinguished into persis-
tent and extended oligoarthritis depending on whether the
disease is confined to four or fewer joints or it extends to
more than four joints after the first 6 months of the illness.
Earlier studies have proposed factors that could predict the
severity in oligoarticular-onset JIA such as high initial ery-
throcyte sedimentation rate (ESR) and involvement of
upper limb. However, more studies are needed for better
and earlier identification of high-risk patients to prevent
possible permanent damages.
Objectives
The aim of the study was to find out prognostic factors
that would predict disease course i.e. who of oligoarticular
JIA patients will have a persistent disease course and who
will develop the extended form. Another target was to
determine whether the main features vary between the
two oligoarticular categories and to see if the outcome is
different between the two groups at 8 years after disease
onset.
Methods
This study is a multicentre population-based follow-up
study in the Nordic countries based on consecutive
patients with a new diagnosis of JIA according to ILAR
criteria. They were enrolled between 1997 and 2000 from
14 geographically defined areas in Finland, Sweden,
Norway and Denmark. Information regarding clinical
data, serology, and disease activity was registered at clini-
cal visits for 8 years.
Results
212 of the 440 JIA patients included in the 8-year study
had oligoarthritis (48.2%). 134 of them had persistent
and 78 extended form. Females constituted 65.7 and
76.9% of the groups, respectively. Mean age at onset was
5.7 for persistent and 5.3 for extended oligoarthritis.
During the 8 years’ follow-up period 18.7% of patients
with persistent and 20.5% with extended oligoarthritis
developed uveitis. The percentage of positive antinuclear
antibodies (ANA) was 42.5 in the persistent and 48.7 in
the extended group. At 8 years the percentage of
patients with active disease was 29.1% for persistent and
60.3% for extended oligoarthritis. When analyzing the
data, both small joint arthritis and inflammation of
joints in upper extremities independently correlated
strongly to a higher number of cumulative joints
(p<0.001). Neither gender, ANA positivity, age at onset,
family history of rheumatic diseases, nor high ESR in
the initial period of the illness correlated to the number
of affected joints in a statistically significant way.
Conclusion
The most striking finding was the poor prognosis of the
extended oligoarthritis category compared to the persis-
tent one; 60% did not reach remission vs. 29%. Upper
limb involvement was a predictor of disease severity,
which is in agreement with previous studies.
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Furthermore, arthritis of small joints predicted develop-
ment to extended oligoarthritis with a high likelihood.
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